The Times – A “universal fingerprint” has been found in the DNA of common cancers that could one day enable a diagnosis to be made with a simple ten-minute blood test.
The Washington Post – The drug approved Monday is for patients with advanced solid tumors containing what’s called an NTRK gene fusion, a hybrid of two genes that can promote uncontrolled cell growth.
STAT– The commissioner of the Food and Drug Administration sounded a note of alarm Wednesday over how hospitals are being paid for custom-built cancer treatments, suggesting that if a solution is not found soon, drug development could suffer.
Science X – In a recent development, aimed at aiding cancer detection and treatment, researchers might have found the ideal surface texture for helping microscopic, medical helpers called nanoparticles to survive in the bloodstream without being screened out by the body's natural defense mechanisms.
CBS19 News – Researchers at the University of Virginia School of Medicine have found a way to help scientists understand the causes of cancer with unprecedented speed.
Gizmodo – Internal documents from IBM show that medical experts working with the company’s Watson supercomputer found “multiple examples of unsafe and incorrect treatment recommendations”.
NBC News – Black men are twice as likely to die of prostate cancer as white men. Government scientists announced that they are launching a study to try to discover why.
The New York Times / The Associated Press – Lawyers for a school groundskeeper dying of cancer asked a San Francisco jury on Monday to find that agribusiness giant Monsanto's widely used weed killer Roundup likely caused his disease.
STAT — Cancer patients are requesting immunotherapy, and expecting miraculous results, despite little evidence for drugs working for their particular cancer.
Quartz —Two new studies published side by side in Nature Medicine dealt a blow to Crispr, suggesting that using the technology in human cells may lead to cancer.